A record fine of more than 400 million euros pronounced against the Swiss laboratories Novartis and Roche by the Competition Authority has been canceled by the Paris Court of Appeal, she announced Thursday.
The two laboratories had been sanctioned in 2020 by the Competition Authority for “abusive practices” aimed at preserving the sales of a drug widely prescribed in ophthalmology, to the detriment of another thirty times cheaper.
More information to come on 20minutes.fr…/…